Iterative Health

The company's business model revolves around the development and deployment of AI and ML technologies in the healthcare sector. One of their key products is SKOUT®, an FDA cleared polyp detection device that aids physicians in detecting adenomas, a precursor to colorectal cancer. This device does not replace physician judgment but enhances it, leading to more accurate diagnoses.

Iterative Scopes also offers services and technology that optimize clinical trials, maximizing the value of clinical research practices. This is achieved through their AI-enabled documentation technology, which improves the quality and continuity of patient care. The technology also allows for standardized, high-quality reporting across institutions, making high-standard care accessible to previously underserved populations.

The company's revenue is likely generated through the sale of their AI and ML technologies and services to healthcare institutions and professionals. They also potentially earn from partnerships with research institutions and pharmaceutical companies for clinical trial optimization.